Array
(
[id] => 12085453
[patent_doc_number] => RE046630
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2017-12-12
[patent_title] => 'Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity'
[patent_app_type] => reissue
[patent_app_number] => 14/858408
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26891
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/858408 | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | Sep 17, 2015 | Issued |
Array
(
[id] => 12197966
[patent_doc_number] => RE046733
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-02-27
[patent_title] => 'Xylanases, nucleic acids encoding them and methods for making and using them'
[patent_app_type] => reissue
[patent_app_number] => 14/732217
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100183
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732217
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732217 | Xylanases, nucleic acids encoding them and methods for making and using them | Jun 4, 2015 | Issued |
Array
(
[id] => 11655414
[patent_doc_number] => RE046423
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2017-06-06
[patent_title] => 'Compositions of engineered human arginases and methods for treating cancer'
[patent_app_type] => reissue
[patent_app_number] => 14/711916
[patent_app_country] => US
[patent_app_date] => 2015-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 17625
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711916
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/711916 | Compositions of engineered human arginases and methods for treating cancer | May 13, 2015 | Issued |